U.S. Food and Drug Administration commissioner Dr. Stephen M. Hahn, alongside President Donald Trump, announced on Friday that the agency had authorized the emergency use of the drug remdesivir as treatment to be used on COVID-19 patients.
- Remdesivir cut coronavirus recovery time by 5 days, company’s final study suggests
- U.S. buys up worldwide stock of remdesivir, drug seen as potential COVID-19 treatment
- Coronavirus drug remdesivir to cost $2,340 per patient in the U.S.